Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer?
β Scribed by Makoto Ohori; J. Kay Dunn; Peter T. Scardino
- Book ID
- 119487963
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 638 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0090-4295
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
ated with higher pathologic stage and grade in patients undergoing radical prostatectomy (RP). In earlier studies, serum prostate specific membrane antigen (PSMA)
Prostate-specific antigen (PSA) is a wellcharacterized human prostate-specific glycoprotein. PSA has been shown to be the most effective immunohistologic marker for prostate cancer, as well as the most useful serologic test in staging and monitoring prostate cancer and in early detection of recurren
Prostate-specific antigen (PSA) is the most accurate serum marker for cancer of the prostate (CAP). However, its sensitivity and specificity are suboptimal, especially at values ranging between 4.1 and 10.0ng/ml (monoclonal), because benign prostatic hypertrophy and hyperplasia (BPH) and CaP frequen